1. Home
  2. EPM vs ALVOW Comparison

EPM vs ALVOW Comparison

Compare EPM & ALVOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPM
  • ALVOW
  • Stock Information
  • Founded
  • EPM 2003
  • ALVOW 2013
  • Country
  • EPM United States
  • ALVOW Luxembourg
  • Employees
  • EPM N/A
  • ALVOW 999
  • Industry
  • EPM Oil & Gas Production
  • ALVOW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EPM Energy
  • ALVOW Health Care
  • Exchange
  • EPM Nasdaq
  • ALVOW Nasdaq
  • Market Cap
  • EPM N/A
  • ALVOW N/A
  • IPO Year
  • EPM 1996
  • ALVOW N/A
  • Fundamental
  • Price
  • EPM $5.21
  • ALVOW $1.51
  • Analyst Decision
  • EPM Strong Buy
  • ALVOW
  • Analyst Count
  • EPM 2
  • ALVOW 0
  • Target Price
  • EPM $7.38
  • ALVOW N/A
  • AVG Volume (30 Days)
  • EPM 167.8K
  • ALVOW 15.0K
  • Earning Date
  • EPM 05-06-2025
  • ALVOW 02-27-2025
  • Dividend Yield
  • EPM 9.23%
  • ALVOW N/A
  • EPS Growth
  • EPM N/A
  • ALVOW N/A
  • EPS
  • EPM 0.04
  • ALVOW N/A
  • Revenue
  • EPM $86,423,000.00
  • ALVOW $393,919,000.00
  • Revenue This Year
  • EPM $4.28
  • ALVOW N/A
  • Revenue Next Year
  • EPM $8.45
  • ALVOW N/A
  • P/E Ratio
  • EPM $124.54
  • ALVOW N/A
  • Revenue Growth
  • EPM N/A
  • ALVOW 517.92
  • 52 Week Low
  • EPM $4.59
  • ALVOW $2.33
  • 52 Week High
  • EPM $6.29
  • ALVOW $2.33
  • Technical
  • Relative Strength Index (RSI)
  • EPM 58.05
  • ALVOW N/A
  • Support Level
  • EPM $4.98
  • ALVOW N/A
  • Resistance Level
  • EPM $5.17
  • ALVOW N/A
  • Average True Range (ATR)
  • EPM 0.10
  • ALVOW 0.00
  • MACD
  • EPM 0.03
  • ALVOW 0.00
  • Stochastic Oscillator
  • EPM 96.71
  • ALVOW 0.00

About ALVOW Alvotech Warrant

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Share on Social Networks: